Expertise in
32
conditions

Reiko Horikawa

Tokyo, JP 
Expertise in
32
conditions
Tokyo, JP 

Overview

Reiko Horikawa practices practicing medicine in Tokyo, Japan.

Ms. Horikawa is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Pediatric Growth Hormone Deficiency, Growth Hormone Deficiency (GHD), Small for Gestational Age, Hormone Replacement Therapy (HRT), and Liver Transplant.

She is actively involved in clinical research, co-authoring 165 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Tokyo, Japan
Other Locations
Setagaya, 1578535, Japan
Japan
Okura, 1578535, Japan
Hongo, 1130033, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Open-Label, Phase 3 Study to Assess the Efficacy and Safety of KRN23 Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With X Linked Hypophosphatemia (XLH)
A Randomized, Open-Label, Phase 3 Study to Assess the Efficacy and Safety of KRN23 Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With X Linked Hypophosphatemia (XLH)
Enrollment Status: Completed
Publish Date: August 29, 2024
Intervention Type: Drug, Biological
Study Phase: Phase 3
A Phase 3, Open-Label, Randomized, Multicenter, 12-month, Efficacy and Safety Study of Weekly MOD-4023 Compared to Daily Genotropin® Therapy in Japanese Pre-pubertal Children With Growth Hormone Deficiency
A Phase 3, Open-Label, Randomized, Multicenter, 12-month, Efficacy and Safety Study of Weekly MOD-4023 Compared to Daily Genotropin® Therapy in Japanese Pre-pubertal Children With Growth Hormone Deficiency
Enrollment Status: Completed
Publish Date: August 12, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

165 Total Publications

Correction to: Consensus and Controversies about Diagnosing GH deficiency - A Delphi Survey by the GH Research Society.
Correction to: Consensus and Controversies about Diagnosing GH deficiency - A Delphi Survey by the GH Research Society.
Journal: Pituitary
Published: July 27, 2026

Frequently Asked Questions about Reiko Horikawa

Is Reiko Horikawa a top-rated expert for Pediatric Growth Hormone Deficiency?

MediFind is an objective health platform that identifies experts based on real-world data. Reiko Horikawa is classified as an Distinguished expert for Pediatric Growth Hormone Deficiency, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Reiko Horikawa participate in research or clinical trials?

Yes. Reiko Horikawa has published 165 articles and abstracts on conditions like Pediatric Growth Hormone Deficiency. You can view a list of Reiko Horikawa's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Horikawa's expertise for a condition
ConditionClose
    View All 9 Distinguished Conditions
    View All 23 Advanced Conditions
    View All 39 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile